Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL

In English

Författare

  • Sara Elsoe
  • Josefin Ahnstrom
  • Christina Christoffersen
  • Andrew N. Hoofnagle
  • Peter Plomgaard
  • Jay W. Heinecke
  • Christoph J. Binder
  • Harry Björkbacka
  • Björn Dahlbäck
  • Lars B. Nielsen

Summary, in English

Objective: Oxidation of LDL plays a key role in the development of atherosclerosis. HDL may, in part, protect against atherosclerosis by inhibiting LDL oxidation. Overexpression of HDL-associated apolipoprotein M (apoM) protects mice against atherosclerosis through a not yet clarified mechanism. Being a lipocalin, apoM contains a binding pocket for small lipophilic molecules. Here, we report that apoM likely serves as an antioxidant in HDL by binding oxidized phospholipids, thus enhancing the antioxidant potential of HDL. Methods and results: HDL was isolated from wild type mice, apoM-deficient mice, and two lines of apoM-Tg mice with similar to 2-fold and similar to 10-fold increased plasma apoM, respectively. Increasing amounts of HDL-associated apoM were associated with an increase in the resistance of HDL to oxidation with Cu2+ or 2,2'-azobis 2-methyl-propanimidamide, dihydrochloride (AAPH) and to an increased ability of HDL to protect human LDL against oxidation. Oxidized phospholipids, but not native phospholipids, quenched the intrinsic fluorescence of recombinant human apoM and the quenching could be competed with myristic acid suggesting selective binding of oxidized phospholipid in the lipocalin-binding pocket of apoM. Conclusions: The results suggest that apoM can bind oxidized phospholipids and that it increases the antioxidant effect of HDL. This new mechanism may explain at least part of the antiatherogenic potential of apoM. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Publiceringsår

2012

Språk

Engelska

Sidor

91-97

Publikation/Tidskrift/Serie

Atherosclerosis

Volym

221

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

Elsevier

Ämne

  • Cardiac and Cardiovascular Systems

Nyckelord

  • Apolipoprotein M
  • HDL
  • Antioxidant
  • Oxidized phospholipids
  • Atherosclerosis

Status

Published

Forskningsgrupp

  • Cardiovascular Research - Immunity and Atherosclerosis
  • Clinical Chemistry, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1879-1484